Merus N.v.
Ticker: MRUS
| Insider | Title |
|---|---|
| Anand Mehra | Director |
| Andrew Joe | SVP, CMO |
| Cecile A W Geuijen | SVP Chief Scientific Officer |
| Fabian Zohren | Chief Medical Officer |
| Gp Holdings Llc Bvf | Director, 10% or greater ownership |
| Gregory D Perry | Chief Financial Officer PFO |
| Harry Shuman | VP Controller, PAO |
| Hui Liu | EVP, CBO Head of Merus US |
| I Gp Llc Bvf | Director, 10% or greater ownership |
| Ii Gp Llc Bvf | Director, 10% or greater ownership |
| Inc/il Bvf | Director, 10% or greater ownership |
| Jason Haddock | Director |
| Kruif John De | SVP Chief Technology Officer |
| Len Kanavy | Director |
| Lex Bakker | SVP, Chief Development Officer |
| Mark N Lampert | Director, 10% or greater ownership |
| Mark T Iwicki | Director |
| Maxine Gowen | Director |
| Paolo Pucci | Director |
| Partners L P/il Bvf | Director, 10% or greater ownership |
| Partners Os Ltd. Bvf | Director, See Explanation of Responses |
| Peter B. Silverman | COO GC |
| Sven Ante Lundberg | President, CEO PEO, Director |
| Value Fund Ii Lp Biotechnology | Director, 10% or greater ownership |
| Value Fund L P Biotechnology | Director, 10% or greater ownership |
| Value Trading Fund Os Lp Biotechnology | Director, See Explanation of Responses |
| Victor Sandor | Director |